Romidepsin (Reach) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: romidepsin, inert substance
Pack: Romidepsin (Reach) (1 x 10 mg vial, 1 x 2 mL inert diluent vial), 1 pack
Brand name
(ARTG)
: ROMIDEPSIN-REACH 10mg powder for injection vial, and solvent for reconstitution vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ROMIDEPSIN-REACH is indicated for the treatment of peripheral T-cell lymphoma in patients who have received at least one prior systemic therapy.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous Infusion
- White Lyophilized cake or Powder
Component :
- Diluent, not applicable
- Intravenous Infusion
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 vial + 1 diluent vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient romidepsin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
